JG 8121 (Symtuza cobicistat 150 mg / darunavir 800 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg)

Generic Name: cobicistat/darunavir/emtricitabine/tenofovir alafenamide

Pill with imprint JG 8121 is Yellow, Capsule-shape and has been identified as Symtuza cobicistat 150 mg / darunavir 800 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg. It is supplied by Janssen Pharmaceuticals, Inc.

Symtuza is used in the treatment of hiv infection and belongs to the drug class antiviral combinations. Symtuza cobicistat 150 mg / darunavir 800 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for JG 8121

Symtuza

Generic Name: cobicistat/darunavir/emtricitabine/tenofovir alafenamide
Imprint: JG 8121
Strength: cobicistat 150 mg / darunavir 800 mg / emtricitabine 200 mg / tenofovir alafenamide 10 mg
Color: Yellow
Size: 22.00 mm
Shape: Capsule-shape
Availability: Prescription only
Drug Class: Antiviral combinations
CSA Schedule: Not a controlled drug
Labeler / Supplier: Janssen Pharmaceuticals, Inc.
National Drug Code (NDC): 59676-0800
Inactive Ingredients: silicon dioxide, croscarmellose sodium, magnesium stearate, microcrystalline cellulose, magnesium silicate, titanium dioxide, ferric oxide yellow
Note: Inactive ingredients may vary.